Royal Bank of Canada’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-202
| Closed | -$24K | – | 8012 |
|
|
2021
Q1 | $24K | Buy |
202
+192
| +1,920% | +$22.7K | ﹤0.01% | 6336 |
|
|
2020
Q4 | $1K | Buy |
+10
| New | +$1.16K | ﹤0.01% | 7027 |
|
|
2020
Q3 | – | Sell |
-200
| Closed | -$20K | – | 7269 |
|
|
2020
Q2 | $20K | Sell |
200
-19
| -9% | -$2.03K | ﹤0.01% | 5604 |
|
|
2020
Q1 | $24K | Hold |
219
| – | – | ﹤0.01% | 5471 |
|
|
2019
Q4 | $25K | Hold |
219
| – | – | ﹤0.01% | 5770 |
|
|
2019
Q3 | $25K | Hold |
219
| – | – | ﹤0.01% | 5411 |
|
|
2019
Q2 | $21K | Buy |
+219
| New | +$20.6K | ﹤0.01% | 5708 |
|
|
2018
Q2 | – | Sell |
-140
| Closed | -$11K | – | 7066 |
|
|
2018
Q1 | $11K | Buy |
+140
| New | +$11.3K | ﹤0.01% | 5700 |
|
|
2017
Q4 | – | Sell |
-6
| Closed | -$1K | – | 7335 |
|
|
2017
Q3 | $1K | Sell |
6
-141,768
| -100% | -$13.6M | ﹤0.01% | 6660 |
|
|
2017
Q2 | $16M | Sell |
141,774
-13
| -0% | -$1.45K | 0.01% | 1202 |
|
|
2017
Q1 | $14.2M | Sell |
141,787
-92
| -0.1% | -$9.83K | 0.01% | 1261 |
|
|
2016
Q4 | $15.3M | Buy |
141,879
+16
| +0% | +$1.87K | 0.01% | 1231 |
|
|
2016
Q3 | $17.7M | Buy |
141,863
+50,314
| +55% | +$5.94M | 0.01% | 1092 |
|
|
2016
Q2 | $9.73M | Buy |
+91,549
| New | +$10.6M | 0.01% | 1477 |
|
|
2016
Q1 | – | Sell |
-28
| Closed | -$4K | – | 6903 |
|
|
2015
Q4 | $4K | Buy |
+28
| New | +$3.23K | ﹤0.01% | 6252 |
|
|
2015
Q1 | – | Sell |
-250
| Closed | -$17K | – | 6588 |
|
|
2014
Q4 | $17K | Hold |
250
| – | – | ﹤0.01% | 5463 |
|
|
2014
Q3 | $13K | Buy |
250
+150
| +150% | +$7.38K | ﹤0.01% | 5413 |
|
|
2014
Q2 | $4K | Buy |
+100
| New | +$4.08K | ﹤0.01% | 5630 |
|
Royal Bank of Canada's CBPO Position: Q2 2021 in Review
Royal Bank of Canada sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 202 shares — an estimated $24K sold.
Royal Bank of Canada first reported a position in CBPO in Q2 2014 and held it in 18 quarters. The position peaked at $17.7M in Q3 2016. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Royal Bank of Canada reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Royal Bank of Canada sold 202 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $24K.
- Royal Bank of Canada first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 18 quarters.
- Royal Bank of Canada's China Biologic Products Holdings, Inc. position peaked at $17.7M in Q3 2016.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Royal Bank of Canada's 13F filing for Q2 2021, filed 16 Aug 2021.